Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II

Autor: Oppegard, Lisa M., Ougolkov, Andrei V., Luchini, Doris N., Schoon, Renee A., Goodell, John R., Kaur, Harneet, Billadeau, Daniel D., Ferguson, David M., Hiasa, Hiroshi
Zdroj: In European Journal of Pharmacology 2009 602(2):223-229
Databáze: ScienceDirect